Latest Conferences, Conference News

VTE Risk Reduced With Partial Knee Replacement

Patients undergoing partial knee replacement have a reduced risk for venous thromboembolism and opioid use in months 3 to 12 after surgery, according to a study presented at the European Congress of Rheumatology, the annual meeting of the European League Against Rheumatism, held from June 12 to 15 in Madrid.

Glucocorticoid Tapering Feasible for Rheumatoid Arthritis Patients

For patients with rheumatoid arthritis achieving low disease activity or remission with tocilizumab, glucocorticoid tapering is associated with a small but significant increase in disease activity compared with continued glucocorticoids, but a majority of patients achieve treatment success with either option. These findings were presented at the European Congress of Rheumatology, the annual meeting of the European League Against Rheumatism, held from June 12 to 15 in Madrid.

ADA: Combo Injectable Controls Blood Glucose Longer in T2DM

Compared with insulin glargine, initial injectable therapy with a combination of insulin degludec and liraglutide aids achievement of blood glucose goals for a longer period of time in patients with uncontrolled type 2 diabetes on oral antidiabetic drugs, according to a study published online June 9 in The Lancet Diabetes & Endocrinology to coincide with the annual meeting of the American Diabetes Association, held from June 7 to 11 in San Francisco.